Pfizer Establishes Potential US$50 M Drug Discovery Pact with University of California, San Diego

By Heather Cartwright

Pharma Deals Review: Vol 2011 Issue 8 (Table of Contents)

Published: 19 Aug-2011

DOI: 10.3833/pdr.v2011.i8.1525     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Through its Centers for Therapeutic Innovation (CTI), Pfizer has entered into a drug discovery and development collaboration with the University of California, San Diego (UCSD) Health Sciences that is potentially worth as much as US$50 M over the next 5 years...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details